Interstitial photodynamic therapy of brain tumors

IEEE Journal on Selected Topics in Quantum Electronics

Volumn 16, Issue 4, 2010, Pages 841-853

  Johansson, Ann ^a   Kreth, Friedrich Wilhelm ^a   Stummer, Walter ^b   Stepp, Herbert ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

5 Aminolevulinic acid (ALA); biomedical applications of optical radiation; brain; fluorescence spectroscopy; malignant glioma; optical propagation in absorbing media; photodynamic therapy (PDT)

Indexed keywords

5-AMINOLEVULINIC ACID; ABSORBING MEDIA; BIOMEDICAL APPLICATIONS; MALIGNANT GLIOMA; OPTICAL PROPAGATION; OPTICAL RADIATIONS;

ACIDS; COMPLEXATION; DATA FLOW ANALYSIS; DOSIMETRY; ELECTROMAGNETIC WAVE ABSORPTION; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; LIGHT PROPAGATION; PHOTOBLEACHING; PHOTODYNAMIC THERAPY; PLASMONS; TUMORS;

PHOTOSENSITIZERS;

EID: 77955513211     PISSN: 1077260X     EISSN: None     Source Type: Journal    
DOI: 10.1109/JSTQE.2009.2033606     Document Type: Article

References (104)

1. H. Ohgaki, "Epidemiology of brain tumors, " Methods Mol. Biol., vol. 472, pp. 323-342, 2009.
2. H. Kostron, T. Fiegele, and E. Akutana, "Combination of FOSCANmediated fluorescence guided resection and photodynamic therapy asnew therapeutic concept for malignant brain tumours, " Med. LaserAppl., vol.21, pp. 285-290, 2006.
3. J. M. Piepmeier, "The future of neuro-oncology, " Acta Neurochir.(Wien.), vol.151, pp. 1343-1348, Jul. 2009.
4. W. Stummer, U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella, and H. J. Reulen, "Fluorescence-guided surgery with 5-aminolevulinic acidfor resection of malignant glioma: A randomised controlled multicentrephase III trial, " Lancet Oncol., vol.7, pp. 392-401, May 2006.
5. U. Pichlmeier, A. Bink, G. Schackert, and W. Stummer, "Resection andsurvival in glioblastoma multiforme: An RTOG recursive partitioninganalysis of ALA study patients, " Neuro Oncol., vol.10, pp. 1025-1034, Dec. 2008.
6. A. A. Potapov, D. J. Usachev, V. A. Loshakov, V. A. Cherekaev, V. N.Kornienko, I. N. Pronin, G. L. Kobiakov, P. L. Kalinin, A. G. Gavrilov, W. Stummer, D. A. Golbin, and P. V. Zelenkov, "First experience in 5-ALA fluorescence-guided and endoscopically assisted microsurgery ofbrain tumors, " Med. Laser Appl., vol.23, pp. 202-208, 2008.
7. A. Claes, A. J. Idema, and P. Wesseling, "Diffuse glioma growth: AGuerilla war, " Acta Neuropathol., vol.114, pp. 443-458, Nov. 2007.
8. N. L. Oleinick, R. L. Morris, and I. Belichenko, "The role of apoptosisin response to photodynamic therapy: What, where, why, and how, "Photochem. Photobiol. Sci., vol.1, pp. 1-21, 2002.
9. J. Dahle, S. Bagdonas, O. Kaalhus, G. Olsen, H. B. Steen, and J. Moan, "The bystander effect in photodynamic inactivation of cells, " Biochim.Biophys. Acta, vol.1475, pp. 273-280, Jul. 2000.
10. D. Kessel and N. L. Oleinick, "Initiation of autophagy by photodynamictherapy, " Methods Enzymol., vol.453, pp. 1-16, 2009.
11. B.W. Henderson and T. J. Dougherty, "How does photodynamic therapywork?" Photochem. Photobiol., vol.55, pp. 145-157, Jan. 1992.
12. V. H. Fingar, "Vascular effects of photodynamic therapy, " J. Clin. LaserMed. Surg., vol.14, pp. 323-328, Oct. 1996.
13. B. Chen, B.W. Pogue, P. J. Hoopes, and T. Hasan, "Vascular and cellulartargeting for photodynamic therapy, " Crit. Rev. Eukaryot. Gene Expr., vol. 16, pp. 279-305, 2006.
14. V. H. Fingar, P. K. Kik, P. S. Haydon, P. B. Cerrito, M. Tseng, E. Abang, and T. J. Wieman, "Analysis of acute vascular damage after photodynamictherapy using benzoporphyrin derivative (BPD), " Br. J. Cancer, vol. 79, pp. 1702-1708, Apr. 1999.
15. A. P. Castano, P. Mroz, and M. R. Hamblin, "Photodynamic therapy andanti-tumour immunity, " Nat. Rev. Cancer, vol.6, pp. 535-545, Jul. 2006.
16. F. H. van Duijnhoven, R. I. Aalbers, J. P. Rovers, O. T. Terpstra, and P. J.Kuppen, "The immunological consequences of photodynamic treatmentof cancer, a literature review, " Immunobiology, vol.207, pp. 105-113, 2003.
17. M. Korbelik, "PDT-associated host response and its role in the therapyoutcome, " Lasers Surg. Med., vol.38, pp. 500-508, Jun. 2006.
18. D. E. J. G. Dolmans, D. Fukumura, and R. K. Jain, " Photodynamictherapy for cancer, " Nature Rev. Cancer, vol.3, pp. 380-387, 2003.
19. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng, "Photodynamic therapy, " J. Nat.Cancer Inst., vol.90, pp. 889-905, Jun. 1998. (Pubitemid 28304157)
20. C. Perria, T. Capuzzo, G. Cavagnaro, R. Datti, N. Francaviglia, C. Rivano, and V. E. Tercero, "First attempts at the photodynamic treatmentof human gliomas, " J. Neurosurg. Sci., vol.24, pp. 119-129, Jul.?1980.
21. H. Kostron, A. Obwegeser, and R. Jakober, "Photodynamic therapy inneurosurgery: A review, " J. Photochem. Photobiol. B, vol.36, pp. 157-168, Nov. 1996.
22. S. S. Stylli and A. H. Kaye, "Photodynamic therapy of cerebral glioma\A review. Part II\Clinical studies, " J. Clin. Neurosci., vol.13, pp. 709-717, Aug. 2006.
23. P. J. Muller and B. C.Wilson, "Photodynamic therapy of brain tumors\A work in progress, " Lasers Surg. Med., vol.38, pp. 384-389, Jun.2006.
24. A. H. Kaye, G. Morstyn, and D. Brownbill, "Adjuvant high-dose photoradiationtherapy in the treatment of cerebral glioma: A phase 1-2study, " J. Neurosurg., vol.67, pp. 500-505, Oct. 1987.
25. S. K. Powers, S. S. Cush, D. L.Walstad, and L. Kwock, "Stereotactic intratumoralphotodynamic therapy for recurrent malignant brain tumors, "Neurosurgery, vol.29, pp. 688-695, 1991.
26. S. S. Stylli, A. H. Kaye, L. MacGregor, M. Howes, and P. Rajendra, "Photodynamic therapy of high grade glioma-long term survival, " J.Clin. Neurosci., vol.12, pp. 389-398, May 2005.
27. P. J. Muller and B. C. Wilson, "Photodynamic therapy for malignantnewly diagnosed supratentorial gliomas, " J. Clin. Laser Med. Surg., vol. 14, pp. 263-270, Oct. 1996.
28. S. S. Stylli, M. Howes, L. MacGregor, P. Rajendra, and A. H. Kaye, "Photodynamic therapy of brain tumours: Evaluation of porphyrin uptakeversus clinical outcome, " J. Clin. Neurosci., vol.11, pp. 584-596, Aug.2004.
29. S. Krishnamurthy, S.K. Powers, P.Witmer, and T. Brown, "Optimal lightdose for interstitial photodynamic therapy in treatment for malignantbrain tumors, " Lasers Surg. Med., vol.27, pp. 224-234, 2000.
30. C. Perria, M. Carai, A. Falzoi, G. Orunesu, A. Rocca, G. Massarelli, N. Francaviglia, and G. Jori, "Photodynamic therapy of malignant braintumors: Clinical results of, difficulties with, questions about, and futureprospects for the neurosurgical applications, " Neurosurgery, vol.23, pp. 557-563, Nov. 1988.
31. P. J. Muller and B. C.Wilson, "Photodynamic therapy of malignant braintumours, " Can. J. Neurol. Sci., vol.17, pp. 193-198, 1990.
32. H. Kostron, 12th World Congress of the International PhotodynamicAssociation, Seattle, WA, 2009.
33. Q. Peng, K. Berg, J. Moan, M. Kongshaug, and J. M. Nesland, "5-Aminolevulinic acid-based photodynamic therapy: Principles and experimentalresearch, " Photochem. Photobiol., vol.65, pp. 235-251, Feb.1997. (Pubitemid 27158805)
34. M. M. El-Sharabasy, A. M. El-Waseef, M. M. Hafez, and S. A. Salim, "Porphyrin metabolism in some malignant diseases, " Br. J. Cancer, vol. 65, pp. 409-412, 1992.
35. S. Kaneko, 12th World Congress of the International PhotodynamicAssociation, Seattle, WA, 2009.
36. S. Collaud, A. Juzeniene, J. Moan, and N. Lange, "On the selectivityof 5-aminolevulinic acid-induced protoporphyrin IX formation, " Curr.Med. Chem. Anti-Cancer Agents, vol.4, pp. 301-316, May 2004.
37. J. F. Greenbaum, Y. Gozlan, D. Schwartz, D. J. Katcoff, and Z. Malik, "Nuclear distribution of porphobilinogen deaminase (PBGD) in gliomacells: A regulatory role in cancer transformation, " Br. J. Cancer, vol.86, no. 6, pp. 1006-1011, 2002.
38. S. R. Ennis, A. Novotny, J. Xiang, P. Shakui, T. Masada, W. Stummer, D. E. Smith, and R. F. Keep, "Transport of 5-aminolevulinic acidbetween blood and brain, " Brain Res., vol.959, pp. 226-234, Jan.2003.
39. H. Stepp, "Fluorescence-guided resections and photodynamic therapy formalignant gliomas using 5-aminolevulinic acid, " in Proc. SPIE, 2005, pp. 547-557.
40. M. S. Eljamel, C. Goodman, and H. Moseley, "ALA and photofrinfluorescence-guided resection and repetitive PDT in glioblastoma multiforme:A single centre Phase III randomised controlled trial, " LasersMed. Sci., vol.23, pp. 361-367, Oct. 2008.
41. T. J. Beck, F. W. Kreth, W. Beyer, J. H. Mehrkens, A. Obermeier, H. Stepp, W. Stummer, and R. Baumgartner, "Interstitial photodynamictherapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX, " Lasers Surg. Med., vol. 39, pp. 386-393, Jun. 2007.
42. T. S. Mang, "Dosimetric concepts for PDT, " Photodiagn. Photodyn.Ther., vol.5, pp. 217-223, Sep. 2008.
43. H. Stepp, T. Beck, T. Pongratz, T. Meinel, F. W. Kreth, J. C. Tonn, and W. Stummer, "ALA and malignant glioma: Fluorescence-guidedresection and photodynamic treatment, " J. Environ. Pathol. Toxicol.Oncol., vol.26, pp. 157-164, 2007.
44. W. Stummer, A. Novotny, H. Stepp, C. Goetz, K. Bise, and H. J. Reulen, "Fluorescence-guided resection of glioblastoma multiforme by using5-aminolevulinic acid-induced porphyrins: A prospective study in 52consecutive patients, " J. Neurosurg., vol.93, pp. 1003-1013, 2000.
45. W. Stummer, S. Stocker, S.Wagner, H. Stepp, C. Fritsch, C. Goetz, A. E.Goetz, R. Kiefmann, and H. J.Reulen, "Intraoperative detection ofmalignantgliomas by 5-aminolevulinic acid-induced porphyrin fluorescence, "Neurosurgery, vol.42, pp. 518-526, 1998.
46. H. Stepp, "Fluorescence guided resection for malignant glioma using5-aminolevulinic acid, " in Proc. SPIE, 2006, pp. 474-480.
47. T. J. Beck, "Clinical determination of tissue optical properties in vivoby spatially resolved reflectance measurements, " in Proc. SPIE, 2003, pp. 96-105.
48. W. Stummer, T. Beck, W. Beyer, J. H. Mehrkens, A. Obermeier, N. Etminan, H. Stepp, J. C. Tonn, R. Baumgartner, J. Herms, and F.W. Kreth, "Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamictherapy using 5-ALA: Case report, " J. Neurooncol., vol.87, pp. 103-109, Mar. 2008.
49. T. C. Zhu, A. Dimofte, J. C. Finlay, D. Stripp, T. Busch, J. Miles, R. Whittington, S. B. Malkowicz, Z. Tochner, E. Glatstein, and S. M. Hahn, "Optical properties of human prostate at 732 nm measuredin vivo during motexafin lutetium-mediated photodynamic therapy, "Photochem. Photobiol., vol.81, pp. 96-105, Jan. 2005.
50. A. Johansson, J. Axelsson, S. Andersson-Engels, and J. Swartling, "Realtimelight dosimetry software tools for interstitial photodynamic therapyof the human prostate, " Med. Phys., vol.34, pp. 4309-4321, Nov.2007.
51. R. A. Weersink, A. Bogaards, M. Gertner, S. R. Davidson, K. Zhang, G. Netchev, J. Trachtenberg, and B. C.Wilson, "Techniques for deliveryand monitoring of TOOKAD (WST09)-mediated photodynamic therapyof the prostate: Clinical experience and practicalities, " J. Photochem.Photobiol. B., vol.79, pp. 211-222, Jun. 2005. (Pubitemid 40668440)
52. J. Li and T. C. Zhu, "Determination of in vivo light fluence distributionin a heterogeneous prostate during photodynamic therapy, " Phys. Med.Biol., vol.53, pp. 2103-2114, Apr. 2008.
53. J. Axelsson, J. Swartling, and S. Andersson-Engels, "In vivo photosensitizertomography inside the human prostate, " Opt. Lett., vol.34, pp. 232-234, Feb. 2009.
54. B. C.Wilson, M. S. Patterson, and L. Lilge, "Implicit and explicit dosimetryin photodynamic therapy, " Lasers Med. Sci., vol.12, pp. 182-199, 1997.
55. I. A. Boere, D. J. Robinson, H. S. de Bruijn, J. Kluin, H. W. Tilanus, H. J. Sterenborg, and R. W. de Bruin, "Protoporphyrin IX fluorescencephotobleaching and the response of rat Barrett's esophagus following5-aminolevulinic acid photodynamic therapy, " Photochem. Photobiol., vol. 82, pp. 1638-1644, Nov. 2006.
56. E. Angell-Petersen, S. Spetalen, S. J. Madsen, C. H. Sun, Q. Peng, S.W.Carper, M. Sioud, and H. Hirschberg, "Influence of light fluence rate onthe effects of photodynamic therapy in an orthotopic rat glioma model, "J. Neurosurg., vol.104, pp. 109-117, Jan. 2006.
57. M. B. Ericson, C. Sandberg, B. Stenquist, F. Gudmundson, M. Karlsson, A. M. Ros, A. Rosen, O. Larko, A. M. Wennberg, and I. Rosdahl, "Photodynamic therapy of actinic keratosis at varying fluence rates: Assessmentof photobleaching, pain and primary clinical outcome, " Br. J.Dermatol., vol.151, pp. 1204-1212, Dec. 2004.
58. W. J. Cottrell, A. D. Paquette, K. R. Keymel, T. H. Foster, and A. R.Oseroff, "Irradiance-dependent photobleaching and pain in deltaaminolevulinicacid-photodynamic therapy of superficial basal cell carcinomas, "Clin. Cancer Res., vol.14, pp. 4475-4483, Jul. 2008.
59. V. X. Yang, P. J. Muller, P. Herman, and B. C. Wilson, "A multispectralfluorescence imaging system: Design and initial clinical tests inintra-operative photofrin-photodynamic therapy of brain tumors, " LasersSurg. Med., vol.32, pp. 224-232, 2003.
60. J. C. Finlay, S.Mitra, M. S. Patterson, and T. H. Foster, "Photobleachingkinetics of photofrin in vivo and in multicell tumour spheroids indicatetwo simultaneous bleaching mechanisms, " Phys. Med. Biol., vol.49, pp. 4837-4860, Nov. 2004.
61. S. K. Bisland, L. Lilge, A. Lin, R. Rusnov, and B. C. Wilson, "Metronomicphotodynamic therapy as a new paradigm for photodynamic therapy:Rationale and preclinical evaluation of technical feasibility for treatingmalignant brain tumors, " Photochem. Photobiol., vol.80, pp. 22-30, Jul. 2004.
62. A. Bogaards, A. Varma, K. Zhang, D. Zach, S. K. Bisland, E. H.Moriyama, L. Lilge, P. J. Muller, and B. C.Wilson, "Fluorescence imageguidedbrain tumour resection with adjuvant metronomic photodynamictherapy: Pre-clinical model and technology development, " Photochem.Photobiol. Sci., vol.4, pp. 438-442, May 2005.
63. A. Molinari, C. Bombelli, S. Mannino, A. Stringaro, L. Toccacieli, A. Calcabrini, M.Colone, A.Mangiola, G. Maira, P. Luciani, G. Mancini, and G.Arancia, "m-THPC-mediated photodynamic therapy of malignantgliomas: Assessment of a new transfection strategy, " Int. J. Cancer, vol. 121, pp. 1149-1155, Sep. 2007.
64. G. R. Reddy, M. S. Bhojani, P. McConville, J. Moody, B. A. Moffat, D. E. Hall, G. Kim, Y. E. Koo, M. J. Woolliscroft, J. V. Sugai, T. D.Johnson, M. A. Philbert, R. Kopelman, A. Rehemtulla, and B. D. Ross, "Vascular targeted nanoparticles for imaging and treatment of brain tumors, "Clin. Cancer Res., vol.12, pp. 6677-6686, Nov. 2006.
65. H. Hirschberg, C. H. Sun, B. J. Tromberg, and S. J. Madsen, "ALAandALA-ester-mediated photodynamic therapy of human gliomaspheroids, " J. Neurooncol., vol.57, pp. 1-7, Mar. 2002.
66. S. M. Wu, Q. G. Ren, M. O. Zhou, Q. Peng, and J. Y. Chen, "ProtoporphyrinIX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester, " Cancer Lett., vol.200, pp. 123-131, Oct. 2003.
67. W. Rachinger, "Untersuchungen zur porphyrin-akkumulation im perifokalengliomgewebe und normalen hirngewebe nach gabe von 5-Aminol̈avulins̈aure, " Ph.D. dissertation, Medizinische Fakulẗat derLudwig-Maximilians-Universiẗat zu M̈unchen, M̈unchen, Germany, 2006.
68. W. Zhang, R. E. Law, D. R. Hinton, and W. T. Couldwell, "Inhibition ofhuman malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor, " Cancer Lett., vol.120, pp. 31-38, Nov. 1997.
69. V. Gupta, Y. S. Su, W. Wang, A. Kardosh, L. F. Liebes, F. M. Hofman, A. H. Schonthal, and T. C. Chen, "Enhancement of glioblastoma cellkilling by combination treatment with temozolomide and tamoxifen orhypericin, " Neurosurg. Focus., vol.20, p. E20, 2006.
70. M. Sarissky, J. Lavicka, S.Kocanova, I. Sulla, A. Mirossay, P. Miskovsky, M. Gajdos, J. Mojzis, and L. Mirossay, "Diazepam enhances hypericininducedphotocytotoxicity and apoptosis in human glioblastoma cells, "Neoplasma, vol.52, pp. 352-359, 2005.
71. R. Ritz, H. T. Wein, K. Dietz, M. Schenk, F. Roser, M. Tatagiba, and W. S. Strauss, "Photodynamic therapy of malignant glioma with hypericin:Comprehensive in vitro study in human glioblastoma cell lines, "Int. J. Oncol., vol.30, pp. 659-667, Mar. 2007.
72. W. Zhang, L. Anker, R. E. Law, D. R. Hinton, R. Gopalakrishna, Q. Pu, U. Gundimeda, M. H. Weiss, and W. T. Couldwell, "Enhancement ofradiosensitivity in human malignant glioma cells by hypericin in vitro, "Clin. Cancer Res., vol.2, pp. 843-846, May 1996.
73. J. T. Wessels, A. C. Busse, M. Rave-Frank, S. Zanker, R. Hermann, E. Grabbe, and G. A. Muller, "Photosensitizing and radiosensitizingeffects of hypericin on human renal carcinoma cells in vitro, " Photochem.Photobiol., vol.84, pp. 228-235, Jan. 2008.
74. J. S. Hill, S. B. Kahl, A. H. Kaye, S. S. Stylli, M. S. Koo, M. F. Gonzales, N. J. Vardaxis, and C. I. Johnson, "Selective tumor uptake of a boronatedporphyrin in an animal model of cerebral glioma, " Proc. Nal. Acad. Sci.USA, vol.89, pp. 1785-1789, Mar. 1992.
75. M. A. Rosenthal, B. Kavar, S. Uren, and A. H. Kaye, "Promising survivalin patients with high-grade gliomas following therapy with a novelboronated porphyrin, " J. Clin. Neurosci., vol.10, pp. 425-427, Jul.2003.
76. G. Zilidis, F. Aziz, S. Telara, and M. S. Eljamel, "Fluorescence imageguidedsurgery and repetitive photodynamic therapy in brain metastaticmalignant melanoma, " Photodiagn. Photodyn. Ther., vol.5, pp. 264-266, Dec. 2008.
77. H. Hirschberg, F. A. Uzal, D. Chighvinadze, M. J. Zhang, Q. Peng, and S. J. Madsen, "Disruption of the blood-brain barrier following ALAmediatedphotodynamic therapy, " Lasers Surg. Med., vol.40, pp. 535-542, Oct. 2008.
78. H. Hirschberg, M. J. Zhang, H. M. Gach, F. A. Uzal, Q. Peng, C. H. Sun, D. Chighvinadze, and S. J. Madsen, "Targeted delivery of bleomycin tothe brain using photo-chemical internalization of clostridium perfringensepsilon prototoxin, " J. Neurooncol., vol.95, pp. 317-329, Jun. 2009.
79. Y. G. Qiang, C. M. Yow, and Z. Huang, "Combination of photodynamictherapy and immunomodulation: Current status and future trends, " Med.Res. Rev., vol.28, pp. 632-644, Jul. 2008.
80. M. Korbelik, B. Stott, and J. Sun, "Photodynamic therapy-generatedvaccines: Relevance of tumour cell death expression, " Br. J. Cancer, vol. 97, pp. 1381-1387, Nov. 2007.
81. H. Zhang, W. Ma, and Y. Li, "Generation of effective vaccines againstliver cancer by using photodynamic therapy, " Lasers Med. Sci., vol.24, pp. 549-552, Jul. 2009.
82. C. J. Gomer, A. Ferrario, M. Luna, N. Rucker, and S. Wong, "Photodynamictherapy: Combined modality approaches targeting the tumormicroenvironment, " Lasers Surg. Med., vol.38, pp. 516-521, 2006.
83. J. Dietrich, A. D. Norden, and P. Y. Wen, "Emerging antiangiogenictreatments for gliomas-efficacy and safety issues, " Curr. Opin. Neurol., vol. 21, pp. 736-744, Dec. 2008.
84. D. Olivier, S. Douilard, and T. Patrice, "PDT-induced in vitro bystandereffect, " 12th World Congress of the International Photodynamic Association, Seattle, WA, vol.7380, 2009, pp. 73803Y-1-73803Y-7.
85. A. Chakraborty, K.D.Held, K.M. Prise, H.L.Liber, and R.W. Redmond, "Bystander effects induced by diffusing mediators after photodynamicstress, " Radiat. Res., vol.172, pp. 74-81, Jul. 2009.
86. S. J. Madsen, E.Angell-Petersen, S. Spetalen, S.W. Carper, S. A. Ziegler, and H. Hirschberg, "Photodynamic therapy of newly implanted gliomacells in the rat brain, " Lasers Surg. Med., vol.38, pp. 540-548, 2006.
87. A. M. Bleau, D. Hambardzumyan, T. Ozawa, E. I. Fomchenko, J. T.Huse, C. W. Brennan, and E. C. Holland, "PTEN/PI3K/Akt pathwayregulates the side population phenotype and ABCG2 activity in gliomatumor stem-like cells, " Cell Stem Cell, vol.4, pp. 226-235, Mar.2009.
88. J. Susanto, Y. H. Lin, Y. N. Chen, C. R. Shen, Y. T. Yan, S. T. Tsai, C. H. Chen, and C. N. Shen, "Porphyrin homeostasis maintained byABCG2 regulates self-renewal of embryonic stem cells, " PLoS One, vol. 3, p. e4023, 2008.
89. B. Olzowy, C. S. Hundt, S. Stocker, K. Bise, H. J. Reulen, and W. Stummer, "Photoirradiation therapy of experimental malignantglioma with 5-aminolevulinic acid, " J. Neurosurg., vol.97, pp. 970-976, Oct. 2002.
90. H. Hirschberg, S. Spetalen, S. Carper, P. Hole, T. Tillung, and S.Madsen, "Minimally invasive photodynamic therapy (PDT) for ablation of experimentalrat glioma, " Minim. Invasive Neurosurg., vol.49, pp. 135-142, Jun. 2006.
91. S. Ito, W. Rachinger, H. Stepp, H. J. Reulen, and W. Stummer, "Oedemaformation in experimental photo-irradiation therapy of brain tumoursusing 5-ALA, " Acta Neurochir., vol.147, pp. 57-65, 2005.
92. W. Stummer, A. Hassan, O. Kempski, and C. Goetz, " Photodynamictherapy within edematous brain tissue: Considerations on sensitizer doseand time point of laser irradiation, " J. Photochem. Photobiol. B, vol.36, pp. 179-181, Nov. 1996.
93. L. Lilge, M. C. Olivo, S. W. Schatz, J. A. MaGuire, M. S. Patterson, and B. C. Wilson, "The sensitivity of normal brain and intracranially implantedVX2 tumour to interstitial photodynamic therapy, " Br. J. Cancer, vol. 73, pp. 332-343, Feb. 1996.
94. M. Olivo and B. C. Wilson, "Mapping ALA-induced PPIX fluorescencein normal brain and brain tumour using confocal fluorescencemicroscopy, " Int. J. Oncol., vol.25, pp. 37-45, Jul. 2004.
95. L. Lilge and B. C.Wilson, "Photodynamic therapy of intracranial tissues:A preclinical comparative study of four different photosensitizers, " J.Clin. Laser Med. Surg., vol.16, pp. 81-91, Apr. 1998.
96. S. Utsuki, H. Oka, S. Sato, S. Shimizu, S. Suzuki, Y. Tanizaki, K. Kondo, Y. Miyajima, and K. Fujii, "Histological examination of false positivetissue resection using 5-aminolevulinic acid-induced fluorescence guidance, "Neurol. Med. Chir (Tokyo), vol.47, pp. 210-213, May 2007.
97. S. Miyatake, T. Kuroiwa, Y. Kajimoto, M. Miyashita, H. Tanaka, and M. Tsuji, "Fluorescence of non-neoplastic, magnetic resonance imagingenhancingtissue by 5-aminolevulinic acid: Case report, " Neurosurgery, vol. 61, pp. E1101-E1103, Nov. 2007.
98. X. Zheng, F. Jiang, M. Katakowski, X. Zhang, H. Jiang, Z. G. Zhang, and M. Chopp, "Sensitization of cerebral tissue in nude mice with photodynamictherapy induces ADAM17/TACE and promotes glioma cellinvasion, " Cancer Lett., vol.265, pp. 177-187, Jul. 2008.
99. H. Hirschberg, C.H. Sun, T. Krasieva, and S. J. Madsen, "Effects of ALAmediatedphotodynamic therapy on the invasiveness of human gliomacells, " Lasers Surg. Med., vol.38, pp. 939-945, Dec. 2006.
100. C. M. Au, S. K. Luk, C. J. Jackson, H. K. Ng, C. M. Yow, and S. S. To, "Differential effects of photofrin, 5-aminolevulinic acid and calphostinC on glioma cells, " J. Photochem. Photobiol. B, vol.85, pp. 92-101, Nov. 2006.
101. F. Jiang, M. Chopp, M. Katakowski, K. K. Cho, X. Yang, N. Hochbaum, L. Tong, and T. Mikkelsen, "Photodynamic therapy with photofrin reducesinvasiveness of malignant human glioma cells, " Lasers Med. Sci., vol. 17, pp. 280-288, 2002. (Pubitemid 35252885)
102. A. Sharwani, W. Jerjes, C. Hopper, M. P. Lewis, M. El Maaytah, H. S. Khalil, A. J. MacRobert, T. Upile, and V. Salih, "Photodynamictherapy down-regulates the invasion promoting factors in human oralcancer, " Arch. Oral Biol., vol.51, pp. 1104-1111, Dec. 2006.
103. A. Uzdensky, A. Juzeniene, L. W. Ma, and J. Moan, " Photodynamicinhibition of enzymatic detachment of human cancer cells from a substratum, "Biochim. Biophys. Acta, vol.1670, pp. 1-11, Jan. 2004.
104. A. Casas, G. Di Venosa, S. Vanzulli, C. Perotti, L. Mamome, L. Rodriguez, M. Simian, A. Juarranz, O. Pontiggia, T. Hasan, and A. Batlle, "Decreased metastatic phenotype in cells resistant to aminolevulinicacid-photodynamic therapy, " Cancer Lett., vol.271, pp. 342-351, Nov. 2008.